We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Takes on Kidney Disease in Innovation Pathway Pilot
FDA Takes on Kidney Disease in Innovation Pathway Pilot
April 13, 2012
Three products for patients with end-stage renal disease (ESRD) could reach the market more quickly, thanks to an expansion of the FDA’s innovation pathway initiative.